IMMP logo

Immutep Limited (IMMP) Company Overview

Profile

Full Name:

Immutep Limited

Sector:

Healthcare

Industry:

Biotechnology

Country:

Australia

IPO:

April 19, 2012

Indexes:

Not included

Website:

http://www.immutep.com

Description:

Immutep Limited is a biotechnology company focused on developing immunotherapy treatments for cancer and autoimmune diseases. They specialize in enhancing the immune system's response to fight diseases, using innovative therapies that target specific proteins to improve patient outcomes.

Key Details

Price

$1.95

Market Cap

$283.64 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

-

Annual EPS

-$0.23(+22.38% YoY)

PE Ratio

-

Annual ROE

-22.11%

Annual Debt To Equity

0.01

Beta

0.63

Events Calendar

Earnings

Next earnings date:

Feb 27, 2025

Recent quarterly earnings:

Feb 27, 2024

Recent annual earnings:

Aug 31, 2022
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Nov 7, 2019

Analyst ratings

Recent major analysts updates

Nov 15, 24 Baird
Outperform
Jun 27, 24 Baird
Outperform
May 17, 24 Capital One
Overweight
Aug 28, 23 Baird
Outperform
Aug 3, 23 Baird
Outperform
Aug 2, 23 Baird
Outperform
May 18, 23 Maxim Group
Buy
Aug 3, 21 Ladenburg Thalmann
Buy
May 29, 18 Maxim Group
Buy

Screeners with IMMP included

Growing Shares Outstanding
Stocks below SMA 200
Healthcare sector
All stocks
Biotechnology industry
Small cap stocks
NASDAQ earnings calendar

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$1.95
IMMP price is $1.95

Price All-time High

$24.00
IMMP price is currently -91.88% below its historical high of $24.00

Price Analysts Target

-
IMMP price consensus analysts' forecast is unknown

Price Most Recent Change

-4.41%
IMMP price was down -4.41% on Feb 14, 2025

Price YTD Change

-7.14%
IMMP price is down -7.14% since January 1st

Price 3-Year Change

-24.12%
IMMP price is down -24.12% over the past 3 years

Market cap

Market Cap

$283.64 M
IMMP market capitalization is $283.64 million

Market Cap 3-Year Change

+26.05%
IMMP market capitalization is up +26.05% over the past 3 years

Market Cap All-time High

$405.54 M
IMMP market capitalization is currently -30.06% below its historical high of $405.54 million

Market Cap Sector Rank

59.38%
IMMP market capitalization is higher than 59.38% of companies in Healthcare sector

Technical

Beta

0.63
IMMP beta is 0.63

200-day SMA

$2.23
IMMP price is currently -12.66% below its 200-day simple moving average

14-day RSI

46.88
IMMP 14-day relative strength index is 46.88

30-day Relative Volume

1.37
IMMP 30-day relative volume is 1.37

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

-
IMMP annual revenue value is unknown

Annual Revenue Analysts Estimate

$4.92 M
IMMP annual revenue is currently equal to the consensus analysts' forecast

Annual Revenue 1-Year Change

-
IMMP annual revenue 1-year change is unknown

Annual Revenue Sector Rank

-
IMMP annual revenue is unknown

Profit

Annual Gross Profit

-
IMMP annual gross profit value is unknown

Annual Gross Margin

-
IMMP annual gross profit margin value is unknown

Annual Operating Profit

-$30.52 M
IMMP annual operating income is -$30.52 million

Annual Operating Margin

-
IMMP annual operating profit margin value is unknown

Annual Net Income

-$28.00 M
IMMP annual net profit is -$28.00 million

Annual Net Margin

-
IMMP annual net profit margin value is unknown

EPS

Annual EPS

-$0.23
IMMP annual earnings per share is -$0.23

Annual EPS Analysts Estimate

-$0.25
IMMP annual earnings per share is currently -7.97% lower than the consensus analysts' forecast

Annual EPS 1-Year Change

+22.38%
IMMP annual earnings per share is up +22.38% year-on-year

Annual EPS Sector Rank

78.46%
IMMP annual earnings per share is higher than 78.46% of companies in Healthcare sector

ROA & ROE

Annual ROA

-20.78%
IMMP annual return on assets is -20.78%

Annual ROE

-22.11%
IMMP annual return on equity is -22.11%

EBIT & EBITDA

Annual EBIT

-$27.98 M
IMMP annual earnings before interest & taxes is -$27.98 million

Annual EBITDA

-$26.50 M
IMMP annual EBITDA is -$26.50 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
IMMP price to earnings ratio value is unknown

PE Ratio Sector Rank

-
IMMP price to earnings ratio is unknown

PB Ratio

PB Ratio

2.24
IMMP price to book ratio is 2.24

PB Ratio Sector Rank

60.77%
IMMP price to book ratio is higher than 60.77% of companies in Healthcare sector

PS Ratio

PS Ratio

-
IMMP price to sales ratio value is unknown

PS Ratio Sector Rank

-
IMMP price to sales ratio is unknown

Enterprise value

Enterprise Value

$176.57 M
IMMP enterprise value is $176.57 million

Enterprise Value Sector Rank

54.56%
IMMP enterprise value is higher than 54.56% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-
IMMP EV/EBITDA value is unknown

EV/EBITDA Sector Rank

-
IMMP EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

18.25
IMMP annual current ratio is 18.25

Annual Quick Ratio

-
IMMP annual quick ratio value is unknown

Leverage

Annual Debt To Equity

0.01
IMMP annual debt to equity ratio is 0.01

Annual Interest Coverage Ratio

-1392.23
IMMP annual interest coverage ratio is -1392.23

Risk & Stability

Piotroski F-Score

-
IMMP piotroski f-score value is unknown

Altman Z-Score

-
IMMP altman z-score value is unknown

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$134.74 M
IMMP annual total assets is $134.74 million

Annual Non Current Assets

$6.84 M
IMMP annual long term assets is $6.84 million

Annual Current Assets

$127.90 M
IMMP annual total current assets is $127.90 million

Annual Cash & Cash Equivalents

$108.14 M
IMMP annual cash & cash equivalents is $108.14 million

Equity

Annual Book Value

$126.68 M
IMMP annual book value is $126.68 million

Annual Working Capital

$120.89 M
IMMP annual working capital is $120.89 million

Liabilities

Annual Total Liabilities

$8.06 M
IMMP annual total liabilities is $8.06 million

Annual Total Long Term Liabilities

$1.05 M
IMMP annual total long term liabilities is $1.05 million

Annual Current Liabilities

$7.01 M
IMMP annual total current liabilities is $7.01 million

Annual Accounts Payable

$2.53 M
IMMP annual accounts payable is $2.53 million

Debt

Annual Total Debt

$1.07 M
IMMP annual total debt is $1.07 million

Annual Total Debt 1-Year Change

+31.03%
IMMP annual total debt is up +31.03% year-on-year

Annual Long Term Debt

$909.10 K
IMMP annual long term debt is $909.10 thousand

Annual Short Term Debt

$156.20 K
IMMP annual short term debt is $156.20 thousand

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$30.52 M
IMMP annual total expenses is $30.52 million

Annual Operating Expenses

$30.52 M
IMMP annual total operating expenses is $30.52 million

Annual Cost Of Goods Sold

-
IMMP annual cost of goods sold value is unknown

Annual SGA

$5.80 M
IMMP annual SGA is $5.80 million

Annual D&A

-
IMMP annual depreciation & amortization value is unknown

Annual Interest Expense

$20.10 K
IMMP annual interest expense is $20.10 thousand

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-
IMMP annual cash flow from operations value is unknown

Annual CFO 1-Year Change

-
IMMP annual cash flow from operations 1-year change is unknown

Annual CFI

-$13.78 M
IMMP annual cash flow from investing activities is -$13.78 million

Annual CFI 1-Year Change

-24638.42%
IMMP annual cash flow from investing activities is down -24638.42% year-on-year

Annual CFF

$62.40 M
IMMP annual cash flow from financing activities is $62.40 million

Annual CFF 1-Year Change

+21.99%
IMMP annual cash flow from financing activities is up +21.99% year-on-year

Free CashFlow

Annual FCF

-
IMMP annual free cash flow value is unknown

Annual FCF 1-Year Change

-
IMMP annual free cash flow 1-year change is unknown

CAPEX

Annual CAPEX

-
IMMP annual capital expenditures value is unknown

Annual CAPEX 1-Year Change

-
IMMP annual capital expenditures 1-year change is unknown

Institutional Ownership

Similar stocks

Alumis (ALMS)
Aardvark Therapeutics (AARD)
KRRO logo
Korro Bio (KRRO)
QSI logo
Quantum-Si incorporated (QSI)
ATYR logo
aTyr Pharma (ATYR)
Anteris Technologies Global Corp (AVR)
RZLT logo
Rezolute (RZLT)
Neumora Therapeutics (NMRA)
CGC logo
Canopy Growth (CGC)

FAQ

  • What is the ticker symbol for Immutep Limited?
  • Does Immutep Limited pay dividends?
  • What sector is Immutep Limited in?
  • What industry is Immutep Limited in?
  • What country is Immutep Limited based in?
  • When did Immutep Limited go public?
  • Is Immutep Limited in the S&P 500?
  • Is Immutep Limited in the NASDAQ 100?
  • Is Immutep Limited in the Dow Jones?
  • When was Immutep Limited's last earnings report?
  • When does Immutep Limited report earnings?

What is the ticker symbol for Immutep Limited?

The ticker symbol for Immutep Limited is NASDAQ:IMMP

Does Immutep Limited pay dividends?

No, Immutep Limited does not pay dividends

What sector is Immutep Limited in?

Immutep Limited is in the Healthcare sector

What industry is Immutep Limited in?

Immutep Limited is in the Biotechnology industry

What country is Immutep Limited based in?

Immutep Limited is headquartered in Australia

When did Immutep Limited go public?

Immutep Limited's initial public offering (IPO) was on April 19, 2012

Is Immutep Limited in the S&P 500?

No, Immutep Limited is not included in the S&P 500 index

Is Immutep Limited in the NASDAQ 100?

No, Immutep Limited is not included in the NASDAQ 100 index

Is Immutep Limited in the Dow Jones?

No, Immutep Limited is not included in the Dow Jones index

When was Immutep Limited's last earnings report?

Immutep Limited's most recent earnings report was on Feb 27, 2024

When does Immutep Limited report earnings?

The next expected earnings date for Immutep Limited is Feb 27, 2025